Pascal Soriot
Net worth: 30 M $ as of 31/12/2025
Profile
Pascal Claude Roland Soriot (born 23 May 1959) is the Chief Executive of the Anglo-Swedish pharmaceutical multinational company AstraZeneca, and has been since October 2012.
Early life
He studied Veterinary Medicine at university (École nationale vétérinaire d'Alfort at Maisons-Alfort in south-east Paris). as a salesman, where he lived in Australia.
AstraZeneca
On 28 August 2012 he was named as the new Chief Executive of AstraZeneca, the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012.
Personal life
He is married with two children and one grandchild.
Source @ Wikipedia
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASTRAZENECA PLC 0.01% | 07/11/2025 | 1,59,899 ( 0.01% ) | 30 M $ | 31/12/2025 |
| 21/05/2025 | 1,173 ( 0% ) | 159 610 $ | 31/12/2025 |
Latest news about Pascal Soriot
Pascal Soriot active positions
| Companies | Position | Start |
|---|---|---|
| ASTRAZENECA PLC | Chief Executive Officer | 01/10/2012 |
| AGILENT TECHNOLOGIES, INC. | Director/Board Member | 20/05/2025 |
Acerta Pharma BV
 Acerta Pharma BV Develops drugs for oncology and autoimmune diseases | Director/Board Member | - |
AstraZeneca Colombia SAS | Chief Executive Officer | 01/10/2012 |
AstraZeneca Österreich GmbH
 AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Chief Executive Officer | - |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Chief Executive Officer | - |
AstraZeneca Holding GmbH
 AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Chief Executive Officer | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Chief Executive Officer | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Board Member | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
Former positions of Pascal Soriot
| Companies | Position | End |
|---|---|---|
| ░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Pascal Soriot
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 21 |
|---|---|
Genentech, Inc.
 Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | |
AstraZeneca PLC
 AstraZeneca PLC Manufactures pharmaceutical products | |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
 Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Hoechst Marion Rousel JP
 Hoechst Marion Rousel JP Miscellaneous Commercial ServicesCommercial Services Conducts medical research | Commercial Services |
AstraZeneca Österreich GmbH
AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Health Technology |
AstraZeneca Colombia SAS | |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Roussel NZ Ltd. | |
École Nationale Vétérinaire d'Alfort
 École Nationale Vétérinaire d'Alfort Functions as a College/University | |
Acerta Pharma BV
Acerta Pharma BV Develops drugs for oncology and autoimmune diseases | |
Viela Bio, Inc.
 Viela Bio, Inc. Operates as clinical-stage biotechnology company which advances treatments for severe inflammation and autoimmune diseases | |
The Sustainable Markets Initiative |
- Stock Market
- Insiders
- Pascal Soriot
